Sequenom Announces Licensing Agreement with Genomic Nanosystems
News Sep 23, 2008
Sequenom, Inc. has announced that it has secured exclusive rights to fundamental patent rights for digital PCR technologies and methods through a licensing agreement with Genomic Nanosystems, LLC, a wholly owned subsidiary of the Cytonix Corporation.
The exclusively licensed rights include United States Patent Nos. 6,143,496 and 6,391,559 and pending applications. The license provides Sequenom with the exclusive right to use digital PCR methods on any platform for noninvasive prenatal diagnostics and analysis for any sample.
Sequenom also secured the exclusive right to use digital PCR methods in conjunction with mass spectrometry for any commercial, diagnostic or research purpose, excluding second generation sequencing. Financial terms were not disclosed.
"Sequenom's extensive intellectual property position in noninvasive prenatal diagnostic testing for the assessment of fetal Down syndrome and other fetal genetic conditions is enhanced by this partnership, enabling us to develop even more highly sensitive tests on our MassARRAY® system, as well as other platforms of our choice in our fields of use," said Harry Stylli, Ph.D., President and Chief Executive Officer of Sequenom.
"We are particularly pleased to be chosen as an exclusive partner by Genomic Nanosystems. These exclusive rights, as well as the licensing agreement we announced last week, further strengthen the proprietary foundation upon which we will continue product development and commercialization in our SEQureDx™ diagnostics business. Furthermore, Sequenom intends to develop a MassARRAY platform-based digital PCR solution for our genomic analysis business and for cancer research and diagnostics," Dr. Stylli continued.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
You Are What Your Mother EatsNews
While many factors, such as the age of the mother, overall health and genetics ultimately play a role, the correlation between a mother’s nutrition habits and metabolism has been proved to directly impact the growth of her child. And researchers believe they may be one step closer to knowing why.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE